Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer
(Q81351655)
scientific article published on 01 June 2008
scientific article published on 01 June 2008
Language:
other details
| description | scientific article published on 01 June 2008 |
External Links
| (P356) |
10.1200/JCO.2007.14.9807
|
| (P698) |
18509179
|